What kind of hilar lung cancer can be a candidate for segmentectomy with curative intent?: Retrospective clinicopathological study of completely resected roentgenographically occult bronchogenic squamous cell carcinoma

被引:11
作者
Endo, C [1 ]
Sagawa, M [1 ]
Sato, M [1 ]
Sakurada, A [1 ]
Aikawa, H [1 ]
Takahashi, S [1 ]
Usuda, K [1 ]
Saito, Y [1 ]
Fujimura, S [1 ]
机构
[1] Tohoku Univ, Dept Thorac Surg, Inst Dev Aging & Canc, Aoba Ku, Sendai, Miyagi 98077, Japan
关键词
bronchoscopy; Hilar lung cancer; range of endoscopic visibility; roentgenographically occult bronchogenic; squamous cell carcinoma; segmentectomy; small peripheral lung cancer;
D O I
10.1016/S0169-5002(98)00040-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although a randomized control trial demonstrated that limited surgery for small peripheral lung cancers was not as curative as lobectomy, there have been no reports concerning segmentectomy for small hilar lung cancers. In this study, we analyzed the clinicopathological features of roentgenographically occult bronchogenic squamous cell carcinomas in order to select candidates for limited resection with curative intent. From April 1982 through June 1995, 105 roentgenographically occult bronchogenic squamous cell carcinomas whose proximal edge of the lesion was more peripheral than the orifice of the segmental bronchus were completely resected. The bronchoscopic findings of the lesions were classified into three categories: remarkable, minute and hidden. Moreover, in terms of the range of endoscopic visibility, the lesions were classified into two categories: lesions within the range of endoscopic visibility and those beyond it. If lymph nodes show no signs of metastasis, roentgenographically occult bronchogenic squamous cell carcinoma is regarded as localized carcinoma and can be a candidate for segmentectomy with curative intent. In cases with minute or hidden bronchoscopic findings or of lesions within the range of endoscopic visibility, metastatic lymph nodes were never observed. Accordingly, roentgenographically occult bronchogenic squamous cell carcinomas with minute or hidden bronchoscopic findings or those within the range of endoscopic visibility can be candidates for curative segmentectomy. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:93 / 97
页数:5
相关论文
共 11 条
[1]   Lymph node involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas: Are these carcinomas candidates for video-assisted lobectomy? [J].
Asamura, H ;
Nakayama, H ;
Kondo, H ;
Tsuchiya, R ;
Shimosato, Y ;
Naruke, T .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1996, 111 (06) :1125-1134
[2]  
*CANC IUA, 1992, TNM CLASS MAL TUM
[3]   RANDOMIZED TRIAL OF LOBECTOMY VERSUS LIMITED RESECTION FOR T1 N0 NON-SMALL-CELL LUNG-CANCER [J].
HOLMES, CE ;
RUCKDESCHEL, JC ;
JOHNSTON, M ;
THOMAS, PA ;
DESLAURIERS, J ;
GROVER, FL ;
HILL, LD ;
FELD, R ;
GINSBERG, RJ ;
MOUNTAIN, CF ;
DZUIBAN, S ;
KIELY, M ;
MCKNEALLY, MF ;
MOORES, DWO ;
RAMNES, C ;
WAGNER, H ;
BUNN, P ;
CHU, H ;
DIENHART, D ;
HAZUKA, M ;
KINZIE, J ;
SORENSEN, J ;
VANCE, V ;
BRAUN, T ;
HOPEMAN, A ;
KANE, M ;
RUSS, P ;
WHITMAN, GJR ;
FALL, SM ;
HANSEN, DP ;
HENDERSON, RH ;
MONCRIEF, CL ;
PAULING, F ;
SIMS, J ;
TELL, D ;
WISELYCARR, S ;
ABERNATHY, CM ;
CLARK, DA ;
MCCROSKEY, B ;
MOORE, G ;
MOORE, F ;
MYERS, A ;
WHITE, M ;
BROOKS, RJ ;
BULL, M ;
JOHNSON, FB ;
NEIMYR, M ;
PAQUETTE, FR ;
SACCOMANNO, G ;
LAD, T .
ANNALS OF THORACIC SURGERY, 1995, 60 (03) :615-622
[4]   CLINICOPATHOLOGICAL ANALYSIS OF 19 CASES OF ISOLATED CARCINOMA IN-SITU OF THE BRONCHUS [J].
NAGAMOTO, N ;
SAITO, Y ;
SATO, M ;
SAGAWA, M ;
KANMA, K ;
TAKAHASHI, S ;
USUDA, K ;
ENDO, C ;
FUJIMURA, S ;
NAKADA, T ;
OHKUDA, K .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1993, 17 (12) :1234-1243
[5]  
NAGAMOTO N, 1994, J BRONCHOL, V1, P23
[6]  
NARUKE T, 1978, J THORAC CARDIOV SUR, V76, P832
[7]  
SAGAWA M, 1990, CANCER, V66, P2653, DOI 10.1002/1097-0142(19901215)66:12<2653::AID-CNCR2820661231>3.0.CO
[8]  
2-U
[9]  
SAITO Y, 1992, J THORAC CARDIOV SUR, V104, P401
[10]  
SATO M, 1993, ACTA CYTOL, V37, P879